IDXX position history
The shares of Idexx Laboratories (IDXX) that Fundsmith LLP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 4,242,202 shares, $2.6B, 7.3% of portfolio
- 2021 Q4: 4,242,283 shares, $2.8B, 6.8% of portfolio, Add 0.0%
- 2022 Q1: 3,618,062 shares, $2B, 6.8% of portfolio, Reduce −14.7%
- 2022 Q2: 3,618,875 shares, $1.3B, 5.6% of portfolio, Add 0.0%
- 2022 Q3: 3,620,777 shares, $1.2B, 5.6% of portfolio, Add +0.1%
- 2022 Q4: 3,443,732 shares, $1.4B, 6.4% of portfolio, Reduce −4.9%
- 2023 Q1: 2,954,196 shares, $1.5B, 6.4% of portfolio, Reduce −14.2%
- 2023 Q2: 2,961,551 shares, $1.5B, 6.2% of portfolio, Add +0.2%
- 2023 Q3: 2,964,554 shares, $1.3B, 5.9% of portfolio, Add +0.1%
- 2023 Q4: 2,728,917 shares, $1.5B, 6.3% of portfolio, Reduce −7.9%
- 2024 Q1: 2,714,762 shares, $1.5B, 5.7% of portfolio, Reduce −0.5%
- 2024 Q2: 2,663,192 shares, $1.3B, 5.3% of portfolio, Reduce −1.9%
- 2024 Q3: 2,664,162 shares, $1.3B, 5.3% of portfolio, Add 0.0%
- 2024 Q4: 2,662,855 shares, $1.1B, 4.7% of portfolio, Reduce 0.0%
- 2025 Q1: 2,648,331 shares, $1.1B, 5.1% of portfolio, Reduce −0.5%
- 2025 Q2: 2,639,289 shares, $1.4B, 6.2% of portfolio, Reduce −0.3%
- 2025 Q3: 2,610,457 shares, $1.7B, 8.4% of portfolio, Reduce −1.1%
- 2025 Q4: 1,876,035 shares, $1.3B, 7.4% of portfolio, Reduce −28.1%
- 2026 Q1: 1,465,786 shares, $824M, 6.4% of portfolio, Reduce −21.9%
- 2026 Q2: 1,019,887 shares, $537M, 3.9% of portfolio, Reduce −30.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|